Takeover Commission Dismisses EQMC, QIF CCF Appeals in U-Blox Takeover
The Takeover Commission (TEC) has dismissed appeals from EQMC Europe Development Capital Fund and QIF CCF - Mercer Investment Fund against Advent Health's takeover bid for U-Blox. EQMC and QIF CCF must now bear procedural costs of 20,000 francs.
Advent Health, through its Polish subsidiary ZI Zenith, has been attempting to acquire U-Blox since September 11, 2025. The company has offered 135 Swiss francs per share, with the takeover period running until October 9, 2025. The U-Blox board has unanimously supported this offer.
The TEC sided with U-Blox and Zenith, fully rejecting the appeals from EQMC and QIF CCF. These funds had criticized the lack of a competitive bidding process and demanded more information on the fairness of the offer price and U-Blox's employee participation plans.
Advent Health's takeover bid for U-Blox remains in progress. EQMC and QIF CCF's appeals have been dismissed, and they must now cover the procedural costs of 20,000 francs.
Read also:
- Small Business Owners Sound Alarm on Tariff Challenges
- THW Marks 75 Years of Saving Lives at Home and Abroad
- Kazakhstan's National Bank Boosts Currency Sales to $1.4 Trillion in Q4
- Federal petition from CEI seeking federal intervention against state climate disclosure laws, alleging these laws negatively impact interstate commerce and surpass constitutional boundaries.
